Dear Colleagues,
It seems the discussion about transgenic approaches to scab resistance is getting off the track a bit. No one (that I've heard) is suggesting transgenics should be the emphasis. Clearly the existing breeding programs must be the most emphasized for the stated reasons - the only approach with hope for quickest help, and an approach with proven track records. Transgenics are a longer term, high-risk, high-payoff approach that needs attention both for the future and in case conventional breeding cannot, at least completely, solve the scab problem. The question then is how much of the total effort should go to transgenics? At the Chicago meeting we penciled in 10%, or $500k (assuming the full 5 mil was appropriated). Since no funds had originally been allocated to transgenics we ran into the problem of where to take it from other areas. In an attempt to help this problem, and to allow breeding programs more lattitude in procuring equipment in the first year to expand their program, I suggested that the 10% might be reduced in the first year because of startup delays (Perry Cregan suggested the same for the $500k proposed for microsatellite development). Although the number of $300k was used, I have since communicated to Rick Ward that $300k was too low and $400k was needed the first year (to return to the $500k in subsequent years). This would represent 8% of the total effort in the first year and 10% in following years. I believe this to be a conservative number consistent with the recognition of all the areas needing support and a balance between hoping to have some useful resistance in the short-term, but accounting for the real possibility that new approaches may be necessary.
Olin Anderson